Use of non-TNF biologics for the treatment of neuro-Behçet’s disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab
(Eur J Rheumatol 2021; 8: 223-227) DOI: 10.5152/eurjrheum.2021.20160
(Eur J Rheumatol 2021; 8: 223-227) DOI: 10.5152/eurjrheum.2021.20160